This company is an immuno-oncology cell therapy business, focused on discovering and developing new therapies that disrupt the cancer treatment landscape. It separated from Bluebird Bio Inc in November 2021.
This company is an immuno-oncology cell therapy business, focused on discovering and developing new therapies that disrupt the cancer treatment landscape. It separated from Bluebird Bio Inc in November 2021.